Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

1407495-04-8

1407495-04-8 structure

1407495-04-8 structure

Name: Ralpancizumab
Chemical Name: Ralpancizumab
CAS Number: 1407495-04-8
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Metabolic Enzyme/Protease Ser/Thr Protease
Create Date: 2023-03-14 12:22:35
Modify Date: 2024-04-08 13:18:00
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke[1].

Name	Ralpancizumab

Description	Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Ser/Thr Protease Research Areas >> Metabolic Disease
References	[1]. Sanz-Cuesta BE, et al. Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke. 2021 Oct;52(10):3142-3150.

No Any Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.